AL Amyloidosis - 146 Studies Found

Completed : Radioimmunoimaging of AL Amyloidosis
: Primary Amyloidosis
: 2008-12-11
: Biological: 124I-labeled monoclonal antibody Mu 11-1F4 Single infusion of radiolabeled antibody: 2 mCi (
Suspended : Trial of HDM/SCT Versus HDM + Bortezomib/SCT in AL Amyloidosis
: AL Amyloidosis
: 2015-03-09
:
  • Drug: Bortezomib

Active, not recruiting : Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis
: AL Amyloidosis
: 2010-10-14
:
  • Drug: Bendamustine

Recruiting : Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
: AL Amyloidosis
: 2016-12-12
:
  • Drug: Venetoclax Venetoclax at
Recruiting : Daratumumab for the Treatment of Patients With AL Amyloidosis
: AL Amyloidosis
: 2016-06-14
: Drug: daratumumab Daratumumab by IV infusion once weekly for two months, then every 2 weeks for four mon
Active, not recruiting : A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
: AL Amyloidosis
: 2012-02-27
:
  • Drug: Pomalidomide Cohort 1 =

Completed : Radioimmunoimaging of Light Chain (AL) Amyloidosis
: AL Amyloidosis
: 2013-03-13
: Biological: Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) Single infusion of 124
Completed : Allo SCT in Amyloidosis Non-interventional Study
: AL Amyloidosis
: 2014-10-02
Active, not recruiting : Quality of Life (QOL) Registry for Patients With AL Amyloidosis
:
  • AL Amyloidosis
  • Amyloidosis

: 2015-10-05
: Other: non-interventional
Recruiting : Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis
: Primary Amyloidosis of Light Chain Type
: 2012-01-10
:
  • Drug: Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of comp
Next >>>